Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Human Hypertension|May 11, 2000
Ambulatory blood pressure monitoring: which arm?J C O'Shea, M B MurphyBlood Pressure Monitoring|June 1, 2000
Electronic activity-monitor-derived sleeping and awake times and diurnal variation of blood pressureJ C O'Shea, M B MurphyAmerican Journal of Hypertension|July 27, 2000
Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping?J C O'Shea, M B MurphyAmerican Journal of Hypertension|February 1, 1997
Factors confounding assessment of ambulatory blood pressure monitors, studied during formal evaluation of the Tycos Quiet-TrakJ C O'Shea, M B MurphyMinerva Cardioangiologica|October 18, 2002
Eptifibatide in percutaneous coronary intervention. A reviewJ P Dery, J C O'Shea, J E TchengThe Journal of Invasive Cardiology|November 4, 2000
Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosisN Burris, R A Lippincott, A Elfe, et al.JAMA|May 23, 2001
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trialJ C O'Shea, G E Hafley, S Greenberg, et al.American Heart Journal|December 2, 2000
Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary interventionJ C O'shea, M Madan, W J Cantor, et al.Journal of the American College of Cardiology|August 31, 2001
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trialJ C Blankenship, G Tasissa, J C O'Shea, et al.Circulation|July 27, 2001
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary interventionI C Gilchrist, J C O'Shea, T Kosoglou, et al.Pageof 2